Review Articles

Measurement of adherence to BCR-ABL inhibitor therapy in chronic myeloid leukemia: current situation and future challenges

Universitair Ziekenhuis Gent, Belgium
Pharmerit BV, Rotterdam, The Netherlands
Pharmerit BV, Rotterdam, The Netherlands
Bristol-Myers Squibb, Paris, France
Bristol-Myers Squibb, Princeton, USA
MWV Healthcare, Sion, Switzerland;University of Liège, Liège, Belgium
Vol. 99 No. 3 (2014): March, 2014 https://doi.org/10.3324/haematol.2012.082511